本页面由Tiger Trade Technology Pte. Ltd.提供服务

Atara Biotherapeutics

5.00
+0.28576.07%
成交量:6.73万
成交额:33.41万
市值:4,085.54万
市盈率:1.94
高:5.06
开:4.91
低:4.73
收:4.71
52周最高:19.15
52周最低:3.92
股本:817.81万
流通股本:560.06万
量比:2.28
换手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):2.57
每股收益(LYR):-11.4053
净资产收益率:-2014.86%
总资产收益率:47.81%
市净率:-1.06
市盈率(LYR):-0.44

数据加载中...

2021/09/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/10

重要事件披露

8-K - Current report
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/09

重要事件披露

8-K - Current report
2021/05/04

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/04

重要事件披露

8-K - Current report
2021/03/01

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/01

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/11

重要事件披露

8-K - Current report
2021/01/08

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/04

重要事件披露

8-K - Current report